Skip to main content
Premium Trial:

Request an Annual Quote

DeltaDot, Partners Get $900K Grant for New Drug Development Tool

NEW YORK (GenomeWeb News) - DeltaDot and Integrated Technologies said today they have received a £465,000 ($900,000) grant from the South East England Development Agency to develop a new tool that will use protein folding structures to help speed drug development.
The system, called the Osprey Biomolecule Stability Analyzer, is a microfluidic instrument that uses DeltaDot's Label Free Intrinsic Imaging to characterize protein properties. The system is being developed to test drug candidates against protein structures and dynamics, the company said.
The company is targeting the market for biopharmaceutical quality assurance as the first application for Osprey. 

ITL director Greg Smith said that the technology is expected to “reduce drug selection times dramatically.”

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.